{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:40:26Z","timestamp":1787611226112,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,8]],"date-time":"2027-01-08T00:00:00Z","timestamp":1799366400000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00042"],"award-info":[{"award-number":["75N93019C00042"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128189","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:17:13Z","timestamp":1767867433000},"page":"128189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A novel calcium influx inducer and a TLR7 agonist are synergistic co-adjuvants that enhance cross-reactive immunity against influenza in young and aged mice"],"prefix":"10.1016","volume":"74","author":[{"given":"Yumi","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renna","family":"Cozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Mclaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Anguiano","family":"Quiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikunj M.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Messer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minya","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maripat","family":"Corr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis A.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2025.128189_bb0005","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1016\/j.vaccine.2020.09.048","article-title":"The disease burden of influenza beyond respiratory illness","volume":"39","author":"Macias","year":"2021","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2025.128189_bb0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jped.2022.12.003","article-title":"The importance of immunization as a public health instrument","volume":"99","author":"Safadi","year":"2023","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.vaccine.2025.128189_bb0015","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/S0140-6736(24)00850-X","article-title":"Contribution of vaccination to improved survival and health: modelling 50 years of the expanded Programme on immunization","volume":"403","author":"Shattock","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.128189_bb0020","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3389\/fmicb.2020.01526","article-title":"Impact of vaccines; health, economic and social perspectives","volume":"11","author":"Rodrigues","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2025.128189_bb0025","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1016\/j.vaccine.2020.11.002","article-title":"Understanding immunosenescence and its impact on vaccination of older adults","volume":"38","author":"Allen","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128189_bb0030","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1016\/j.vaccine.2009.02.004","article-title":"MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination","volume":"27","author":"Vesikari","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128189_bb0035","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.4049\/jimmunol.178.8.5271","article-title":"Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release","volume":"178","author":"Li","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.128189_bb0040","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/14760584.2024.2382725","article-title":"Adjuvant system AS01: from mode of action to effective vaccines","volume":"23","author":"Roman","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.128189_bb0045","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.128189_bb0050","first-page":"626","article-title":"FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the advisory committee on immunization practices (ACIP)","volume":"59","author":"Centers for Disease C, Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.128189_bb0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","article-title":"Next-generation influenza vaccines: opportunities and challenges","volume":"19","author":"Wei","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2025.128189_bb0060","doi-asserted-by":"crossref","first-page":"10432","DOI":"10.1038\/s41598-018-28706-1","article-title":"The influenza virus hemagglutinin head evolves faster than the stalk domain","volume":"8","author":"Kirkpatrick","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.128189_bb0065","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1128\/JVI.03337-14","article-title":"Synthetic toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses","volume":"89","author":"Goff","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.128189_bb0070","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3389\/fimmu.2020.01207","article-title":"A novel synthetic dual agonistic liposomal TLR4\/7 adjuvant promotes broad immune responses in an influenza vaccine with minimal reactogenicity","volume":"11","author":"Sato-Kaneko","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.128189_bb0075","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1021\/acschembio.3c00134","article-title":"Identification of a novel small molecule that enhances the release of extracellular vesicles with Immunostimulatory potency via induction of calcium influx","volume":"18","author":"Sako","year":"2023","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.vaccine.2025.128189_bb0080","doi-asserted-by":"crossref","first-page":"13703","DOI":"10.1021\/acs.jmedchem.4c00491","article-title":"Structure-activity relationship studies in Benzothiadiazoles as novel vaccine adjuvants","volume":"67","author":"Belsuzarri","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.vaccine.2025.128189_bb0085","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.4049\/jimmunol.170.8.4102","article-title":"A subset of toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells","volume":"170","author":"Datta","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.128189_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/262394","article-title":"Mast cell-mediated inhibition of abdominal neutrophil inflammation by a PEGylated TLR7 ligand","volume":"2012","author":"Hayashi","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.vaccine.2025.128189_bb0095","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","article-title":"SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets","volume":"20","author":"Zheng","year":"2022","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.vaccine.2025.128189_bb0100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025718118","article-title":"Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection","volume":"118","author":"Sato-Kaneko","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2025.128189_bb0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-1759(98)00015-5","article-title":"The need for IgG2c specific antiserum when isotyping antibodies from C57BL\/6 and NOD mice","volume":"212","author":"Martin","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2025.128189_bb0110","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.181.2.713","article-title":"T cell genetic background determines default T helper phenotype development in vitro","volume":"181","author":"Hsieh","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2025.128189_bb0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2025.128189_bb0120","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.shk.0000142249.08135.e9","article-title":"Innate immune response in Th1- and Th2-dominant mouse strains","volume":"22","author":"Watanabe","year":"2004","journal-title":"Shock"},{"key":"10.1016\/j.vaccine.2025.128189_bb0125","article-title":"Hemagglutination inhibition antibody titers as a correlate of protection against seasonal a\/H3N2 influenza Disease. Open forum","volume":"2","author":"Benoit","year":"2015","journal-title":"Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128189_bb0130","doi-asserted-by":"crossref","first-page":"e00416","DOI":"10.1128\/mBio.00417-16","article-title":"Evaluation of Antihemagglutinin and Antineuraminidase antibodies as correlates of protection in an influenza a\/H1N1 virus healthy human challenge model","volume":"7","author":"Memoli","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2025.128189_bb0135","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.3390\/v6083159","article-title":"Options and obstacles for designing a universal influenza vaccine","volume":"6","author":"Jang","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.128189_bb0140","doi-asserted-by":"crossref","first-page":"17736","DOI":"10.1073\/pnas.0807142105","article-title":"Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion","volume":"105","author":"Russell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2025.128189_bb0145","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci"},{"key":"10.1016\/j.vaccine.2025.128189_bb0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-4838(00)00153-9","article-title":"Alpha-1-acid glycoprotein","volume":"1482","author":"Fournier","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2025.128189_bb0155","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/gut.51.3.398","article-title":"Overexpression of alpha(1)-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis","volume":"51","author":"Hochepied","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.vaccine.2025.128189_bb0160","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/361841","article-title":"A new method for the evaluation of vaccine safety based on comprehensive gene expression analysis","volume":"2010","author":"Momose","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2025.128189_bb0165","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/507558","article-title":"Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease","volume":"194","author":"Thompson","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128189_bb0170","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4161\/hv.22908","article-title":"Correlates of protection to influenza virus, where do we go from here?","volume":"9","author":"Cox","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128189_bb0175","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1586\/14760584.2013.824709","article-title":"The evolving history of influenza viruses and influenza vaccines","volume":"12","author":"Hannoun","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.128189_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127281","article-title":"Guided design for the development of an evolution-proof influenza vaccine","volume":"59","author":"Myburgh","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128189_bb0185","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1080\/14760584.2022.2072301","article-title":"Next generation live-attenuated influenza vaccine platforms","volume":"21","author":"Ullah","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.128189_bb0190","doi-asserted-by":"crossref","first-page":"17585","DOI":"10.1073\/pnas.1207308109","article-title":"Adjuvant solution for pandemic influenza vaccine production","volume":"109","author":"Clegg","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2025.128189_bb0195","doi-asserted-by":"crossref","first-page":"2517137","DOI":"10.1080\/10717544.2025.2517137","article-title":"Advances in vaccine adjuvant development and future perspectives","volume":"32","author":"Sinani","year":"2025","journal-title":"Drug Deliv"},{"key":"10.1016\/j.vaccine.2025.128189_bb0200","first-page":"11","article-title":"Advances in adjuvanted influenza vaccines","author":"Shichinohe","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.128189_bb0205","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.vaccine.2019.01.052","article-title":"Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), vaccine adverse event reporting system (VAERS), United States, July 2016-June 2018","volume":"37","author":"Haber","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128189_bb0210","first-page":"S7","article-title":"Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children and adults 65 years of age and older","volume":"85S","author":"Lindert","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128189_bb0215","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.vaccine.2017.11.019","article-title":"Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: results of a phase III, randomized, open-label, multicenter study","volume":"36","author":"Lal","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128189_bb0220","doi-asserted-by":"crossref","first-page":"33581","DOI":"10.18632\/oncotarget.9254","article-title":"Vaccine efficacy and T helper cell differentiation change with aging","volume":"7","author":"Lefebvre","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.vaccine.2025.128189_bb0225","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.molmed.2022.09.008","article-title":"How aging impacts vaccine efficacy: known molecular and cellular mechanisms and future directions","volume":"28","author":"Chen","year":"2022","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.vaccine.2025.128189_bb0230","first-page":"10","article-title":"Aging and interferons: impacts on inflammation and viral disease outcomes","author":"Feng","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.vaccine.2025.128189_bb0235","first-page":"474","article-title":"Interferon-gamma - inducible inflammation: contribution to aging and aging-associated psychiatric disorders","volume":"2","author":"Oxenkrug","year":"2011","journal-title":"Aging Dis"},{"key":"10.1016\/j.vaccine.2025.128189_bb0240","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1474-9726.2009.00478.x","article-title":"Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels","volume":"8","author":"Yuan","year":"2009","journal-title":"Aging Cell"},{"key":"10.1016\/j.vaccine.2025.128189_bb0245","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/infdis\/jit372","article-title":"Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children","volume":"208","author":"Ng","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128189_bb0250","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/lam.13513","article-title":"Comparison of hemagglutination inhibition and hemagglutinin pseudovirus neutralization titres in relation to protection against influenza in a mouse model","volume":"73","author":"Huang","year":"2021","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.vaccine.2025.128189_bb0255","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/infdis\/jiae122","article-title":"Hemagglutination inhibition antibody titers as mediators of influenza vaccine efficacy against symptomatic influenza A(H1N1), A(H3N2), and B\/Victoria virus infections","volume":"230","author":"Lim","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128189_bb0260","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1021\/bc900054q","article-title":"Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates","volume":"20","author":"Chan","year":"2009","journal-title":"Bioconjug Chem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:47:41Z","timestamp":1773971261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25014872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":52,"alternative-id":["S0264410X25014872"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128189","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel calcium influx inducer and a TLR7 agonist are synergistic co-adjuvants that enhance cross-reactive immunity against influenza in young and aged mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128189"}}